Tibet Pharmaceuticals Exec Escapes Class Action Over IPO
A New Jersey federal judge has allowed a director of a Tibetan pharmaceutical company to escape an investor class action alleging the company lied about its financial health ahead of a...To view the full article, register now.
Already a subscriber? Click here to view full article